COVID-19 lambda variant: What to know
Health officials are keeping their eye on several COVID-19 mutations, including the lambda variant, which is starting to attract more attention — although not yet as much as the delta variant.
The World Health Organization first officially identified the lambda variant, or C.37, on June 14, 2020, pointing to a case in Peru that was documented in December 2020.
WHO officials said not much is known about the projected impact of the lambda variant, but there is the potential of increased transmissibility or possible increased resistance to neutralizing antibodies compared to the original COVID-19 strain. Researchers said more studies are needed to understand the variant.
WHO officials said not much is known about the projected impact of the lambda variant, but there is the potential of increased transmissibility or possible increased resistance to neutralizing antibodies compared to the original COVID-19 strain. Researchers said more studies are needed to understand the variant.
The World Health Organization first officially identified the lambda variant, or C.37, on June 14, 2020, pointing to a case in Peru that was documented in December 2020.
WHO officials said not much is known about the projected impact of the lambda variant, but there is the potential of increased transmissibility or possible increased resistance to neutralizing antibodies compared to the original COVID-19 strain. Researchers said more studies are needed to understand the variant.
WHO officials said not much is known about the projected impact of the lambda variant, but there is the potential of increased transmissibility or possible increased resistance to neutralizing antibodies compared to the original COVID-19 strain. Researchers said more studies are needed to understand the variant.
Comment